This Solicitation opportunity from Department Of Defense was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

ISONIAZID TABLETS, U

Closed

SPE2DP-26-T-3401Federal

Submission Closed05/20/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Supply of PYP Cold VialsThe contract involves the supply of PYP cold vials to the VA Pittsburgh facility, requiring a stringent same-day delivery service within a 2-hour window during business hours. The supplier must ensure the maintenance of the cold chain throughout the delivery process, complying with all relevant regulatory standards to preserve the integrity of the product. This contract is categorized under NAICS code 325412 and is managed by the Department of Veterans Affairs, specifically through the 244-NETWORK Contract Office 4. Responses to this subcontract opportunity must be submitted by July 10, 2026. The contract emphasizes urgency and precision in delivery, reflecting the critical nature of the supplies for the facility's operations. The detailed logistics and regulatory compliance underscore the importance of reliability and quality control in fulfilling the contract requirements. Information about the contract was made available as of June 12, 2026.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

PETNET PharmaceuticalThe Medical Readiness Contracting Office-West plans to award a firm fixed-price sole source contract to PETNET Solutions INC., doing business as Siemens Healthineers, for the supply of FDA-approved radiopharmaceuticals including FDG, NaF, Amyvid, and Posluma. The contract encompasses a base period from October 1, 2026, to September 30, 2027, with an option period extending to September 30, 2028. This contract will be executed under statutory authority FAR 12.102(a), allowing for non-competitive procurement due to the determination that only one source is reasonably available to meet the government's specific needs. The contract falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,300 employees. The delivery location for the products will be the William Beaumont Army Medical Center at Fort Bliss, Texas. The notice explicitly states that no competitive proposals will be solicited, and the government will not honor any capability briefings or telephonic inquiries related to this contract. The point of contact for inquiries is Darryl O. Bryant, with a secondary contact being Karina Haddix, both representatives of the Department of Defense’s Medical Readiness Contracting Office-West.

W40M MRC0 West

POSTED

5 days ago

DEADLINE

in 6 days

AI Contract Overview

The contract covers the procurement of Isoniazid Tablets, USP, 300 mg, packaged in bottles containing 100 tablets each, with a total order quantity of 2 bottles. The items are subject to strict packaging and labeling requirements, including adherence to the Defense Logistics Agency’s (DLA) Medical Marking Standard No. 1 and packaging protocols designed to ensure protection against damage during shipping. Packaging must comply with commercial standards suitable for transport by common carriers, with specific instructions to avoid any intentional addition or contact with mercury or mercury compounds unless specified exceptions apply. The shelf life for this type I (code Q) pharmaceutical item is specified as 36 months and is non-extendable. Delivery is required within 20 days, with destination FOB, inspection, and acceptance all conducted at the destination point. The contract includes references to multiple DLA technical and quality stipulations, which take precedence over general packaging standards, and it emphasizes compliance with federal hazardous material packaging instructions if applicable. All labeling and marking specifications must comply with current DoD regulations, and vendors are instructed to utilize the appropriate unit of issue and pack quantities as defined by the DLA. The contract also mandates the removal of government identification from any rejected supplies and requires communication with a designated product specialist for FDA-regulated status confirmation. The contracting agency is the Department of Defense’s Medical Supply Chain Pharmacy FSA, with point of contact Vanesa M Carbo Acevedo. The delivery location is FPO AP 96678, with a final delivery date of May 18, 2026.

General Info

Procurement of 2 bottles Isoniazid Tablets 300mg, strict DLA packaging, deliver by May 18, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

UNIT 100494 BOX 1, FPO, AP, 96678, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3401.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 14

Solicitation

Response DeadlineMay 20

Deadline has passed

Submission Closed

05/20/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

Vanesa M Carbo Acevedo

contact@example.gov

+1 (555) 000-0000

Full Description

ISONIAZID TABLETS,U
ISONIAZID TABLETS,USP, 300 MG,100'S UNIT OF ISSUE "BOTTLE"
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 BT = 100 TT
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
SPE2DP-26-T-3401
SECTION B
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
GENUS LIFESCIENCES INC 7BH52 P/N NDC64950-0217-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016779806 0001 BT 2.000
NSN/MATERIAL:6505001326904
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
SPE2DP-26-T-3401
SECTION B
PR: 7016779806 PRLI: 0001 CONT’D
UNIT 100494 BOX 1
FPO AP 96678
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N231936133S300
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YPHARM SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3401 NSN/Part Number: 6505-00-132-6904 Quantity: 2 BT Purchase Request: 7016779806QTY: 2 Delivery: 20 days ADO